Morphine Withdrawn Phase 2 Trials for Hb-SS Disease With Vasoocclusive Pain / Hemoglobin SS Disease With Vasoocclusive Crisis / Sickle Cell Disease (SCD) / Hemoglobin SS Disease With Crisis / Other Sickle Cell Disease With Vaso-Occlusive Pain Treatment

Indications	Status	Purpose	Phase
DBCOND0065801 (Hb-SS Disease With Vasoocclusive Pain) DBCOND0065802 (Hemoglobin SS Disease With Vasoocclusive Crisis) DBCOND0128712 (Sickle Cell Disease (SCD)) DBCOND0065804 (Hemoglobin SS Disease With Crisis) DBCOND0065803 (Other Sickle Cell Disease With Vaso-Occlusive Pain)	Withdrawn	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
https://clinicaltrials.gov/ct2/show/	Abciximab (ReoPro) as a Therapeutic Intervention for Sickle Cell Vaso-Occlusive Pain Crisis	Abciximab (DB00054) Fentanyl (DB00813) Hydromorphone (DB00327) Ibuprofen (DB01050) Morphine (DB00295)